Related Experiment Video
Updated: Nov 26, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo
Yutaro Asami1, Tetsuya Nagata1, Kotaro Yoshioka1
1Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan; Center for Brain Integration Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
This study introduces a novel antisense oligonucleotide (ASO)/DNA heteroduplex for enhanced gene silencing. This new design shows comparable efficacy and liver accumulation to previous ASO/RNA structures, expanding therapeutic options.
Area of Science:
- Oligonucleotide chemistry
- Antisense technology
- Molecular therapeutics
Background:
- Antisense oligonucleotide (ASO) therapeutics offer targeted gene silencing.
- Previous DNA/RNA heteroduplexes showed enhanced in vivo efficacy when conjugated with α-tocopherol.
- Optimization of heteroduplex design is crucial for improved therapeutic potential.
Purpose of the Study:
- To design and evaluate a new antisense oligonucleotide (ASO)/DNA heteroduplex.
- To investigate the structure-activity relationships of the DNA-based complementary strand.
- To assess the in vivo stability and efficacy of the ASO/DNA heteroduplex.
Main Methods:
- Synthesis of ASO/DNA heteroduplex oligonucleotides with varying modifications.
- In vivo evaluation of gene silencing activity and liver accumulation.
- Analysis of complementary strand degradation kinetics.
Main Results:
- The ASO/DNA heteroduplex demonstrated similar gene silencing activity and liver accumulation compared to the ASO/RNA design.
- Optimal potency and accumulation were achieved with 2'-O-methyl RNA and phosphorothioate modifications on the DNA complement flanks.
- Both DNA and RNA complementary strands were fully degraded in vivo.
Conclusions:
- ASO/DNA heteroduplexes represent a viable alternative to ASO/RNA designs for gene silencing.
- Specific chemical modifications enhance the performance of DNA-based complementary strands.
- This technology broadens the chemical modification strategies available for oligonucleotide therapeutics.
Related Concept Videos
In-vitro Mutagenesis
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

